Incyte Corp (NASDAQ:INCY)

72.98
Delayed Data
As of Jun 19
 +0.96 / +1.33%
Today’s Change
60.23
Today|||52-Week Range
140.11
-22.94%
Year-to-Date
Abbvie's (ABBV) Upadacitinib Fifth RA Study Data Positive
Jun 06 / Zacks.com - Paid Partner Content